Almost two years after the first case of COVID-19 was discovered in Portugal, it continues to be a challenging disease for the scientific community.
The incubation period for this disease (COVID-19) is about 4 to 5 days after exposure to the virus. The World Health Organization (WHO) reports that most positive COVID-19 cases (approximately 80-85%) manifest clinically as mild or asymptomatic form of seasonal flu. The most common symptoms include fever, sore throat, cough, headache, muscle or joint pain, loss of taste or smell, and diarrhea.
Other expressions
In 10 to 15% of cases, the disease has severe manifestations, sometimes requiring respiratory distress and invasive mechanical ventilation.
Pulmonary recurrences such as fibrosis are well documented in these cases, however, there are asymptomatic patients in the acute phase of the disease who also develop chronic symptoms.
Although most patients fully recover within 3-4 weeks, in some cases the symptoms may persist or recur, with recovery from Covit-19 lasting weeks or even months.
These long-running sequels to Govt-19, in the post-recovery phase, have many authors “Long-COVID ”,“ Long-term effects of COVID-19 ”,“ Continuous symptoms of COVID-19 ”or“ Post-COVID-19 syndrome ”. Most recently term Long-Covid is recognized by the scientific community and is widely used in many publications.
What is a long govt?
This company is defined by, The Long-Covit, a condition characterized by multiple clinical manifestations of respiratory, cardiovascular, neurological, gastrointestinal, renal, and / or musculoskeletal disorders, usually appearing in the acute phase or immediately after infection, not explained by alternative diagnosis. And the disease lasts for more than four weeks.
Some studies classify this substance according to the duration of the symptoms: “post-acute goiter”, symptoms lasting 4 to 12 weeks after an acute infection, and “chronic goiter” lasting more than 12 weeks.
No direct link between clinical severity and risk of acute illness has been demonstrated. Long-Govid.
With about 10 to 30% of Govit-19 patients evolving into Long-Govit, it is easy to understand the impact that the company has and will have on the daily lives of the affected patients, health costs and non-attendance. The Long Govt There is no trial, characterization and comprehensive diversification of treatment.
One of the most important tasks we have to do is to identify these sequences correctly.
What are the symptoms?
The most common symptoms in cases Long-Govid Almost all studies conducted on these patients include persistent fatigue and dyspnea. Other common symptoms include: cough, joint pain, chest pain or tightness, headache, loss of smell / taste, sore throat, diarrhea, memory loss, depression, anxiety. In addition, some less frequent symptoms are insomnia, palpitations, loss of appetite, skin rash and hair loss.
Extrapulmonary manifestations include heart problems, neurological manifestations, mental disorders, and renal manifestations.
After acute SARS-CoV-2 infection, in some studies 20% of patients have cardiopulmonary complications, i.e. myocardial infarction, pericarditis, acute myocardial infarction, dysrhythmia or thromboembolic events.
Studies conducted on these patients suggest avoiding intensive cardiovascular exercise for three months after myocarditis / pericarditis. For athletes, after adequate evaluation and follow-up, this period should last from three to six months.
Particular emphasis should be placed on the individual’s reaction to the infection, focusing on the patient’s mental health and potential complaints related to anxiety, stress, changes in practice, loneliness and loneliness.
Adequate clinical evaluation is required
Due to the persistence of the infection, new waves and variations of the SARS-CoV-2 virus, Long-COVID is an increasingly relevant and widespread health problem worldwide.
Therefore a comprehensive investigation is important to understand all aspects related to the long-term effects of Govit-19.
To date, physicians and researchers have focused their attention on the current active stage of the disease. But, even after recovery and discharge, it is important to monitor these patients.
After Govit 19, proper clinical evaluation is essential to identify symptoms, diagnose and treat complications of the disease.
To not only improve the quality of life of these patients, but also to contribute to their return to an active life, the Physiocospar Clinic developed post-trial counseling Covit-19.
Testing is essential for all sufferers, including those with mild and mild symptoms. It is important to monitor the appearance of new symptoms, persistent symptoms or progressive worsening, especially in patients with chronic diseases.
Article by Dr. Eduardo Commanda, an expert in internal medicine at Clinica Physiokasper.